It seems to me that if, at almost any point at all over the last few years, a potential MSB investor came to Hot Copper and was influenced by Madamswer to not make a MSB purchase then Madam has done them a service. Because he has correctly called the absence of a revenue/profit generating ability and risk to invested capital.
By comparison Anjo, and some others, have been spruiking this stock since at least 2014 when it was priced at $4.83.
Whose advice has actually helped investors? Are we to leave new HC members to only hear an echo chamber constantly spruiking the stock in what could possibly be described as an emotional and hope based point of view?
As a newer member I would rather have an open forum, where it is ok to disagree and compare facts, viewpoints, data, etc. Why would anyone want to close down debate just because they disagree? Maybe a better approach would be to try and work out WHY the other person thinks what they think and reassess whether your capital is deployed in the best possible way.
Anyway my 2c best wishes for great results for all.
- Forums
- ASX - By Stock
- MSB
- FDA announce new policy approach
FDA announce new policy approach, page-39
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.39 |
Change
-0.005(0.36%) |
Mkt cap ! $1.581B |
Open | High | Low | Value | Volume |
$1.40 | $1.42 | $1.38 | $4.391M | 3.156M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 48253 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 32922 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 48253 | 1.385 |
5 | 70251 | 1.380 |
15 | 100605 | 1.375 |
8 | 96825 | 1.370 |
3 | 43018 | 1.365 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 32922 | 2 |
1.400 | 77386 | 10 |
1.405 | 24018 | 1 |
1.410 | 116617 | 7 |
1.415 | 58649 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online